A double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy with health-related quality of life as an outcome measure
- 30 September 2000
- Vol. 9 (6) , 375-379
- https://doi.org/10.1053/seiz.2000.0428
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Lamotrigine Monotherapy in Newly Diagnosed Untreated Epilepsy: A Double‐Blind Comparison with PhenytoinEpilepsia, 1999
- Quality of Life of People with Epilepsy: A European StudyEpilepsia, 1997
- The associations of psychopathology in epilepsy: a community studyEpilepsy Research, 1996
- Standardisation of a self-report questionnaire for use in evaluating cognitive, affective and behavioural side-effects of anti-epileptic drug treatmentsEpilepsy Research, 1996
- Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsyThe Lancet, 1995
- Informative Drop-Out in Longitudinal Data AnalysisJournal of the Royal Statistical Society Series C: Applied Statistics, 1994